Be the first to meet the Fierce 15 next week

Arsalan Arif, Publisher
follow me on twitter

Next week arrives our most anticipated feature yet: The Fierce 15. Our veteran biotech news team lead by John Carroll and Ryan McBride assembled one of our best classes ever. We can't wait to share it with you.

To be the first to know:

  • Visit FierceBiotech at 9:00AM ET on Tuesday, September 6
  • Follow @FierceBiotech on twitter
  • Subscribe to FierceBiotech if you haven't already, or send the link to a colleague

And to be the first to meet a few of our winners in person, attend BioPharm America 2011 in Boston. The meeting starts in just a few short days. (Direct registeristration link here.) Several Fierce 15 CEOs will take questions from John Carroll in a unique "Fierce 15 Revealed" session on Sept. 7 at BioPharm America 2011, which is produced by EBD Group. We've long collaborated on successful projects with EBD Group serving the biotech and pharma dealmaking communities.

They also know how to throw a party. I'll be there with John and Ryan and hope to see you there too.

Thanks for being part of the Fierce community.

- Arsalan Arif, Group Publisher
Questions? Ideas? E-mail me

Suggested Articles

Across its 15-year history, Omega Funds has a hand in a clutch of high-profile biotechs such as Editas Medicine and Juno Therapeutics.

After Novartis’ near $10 billion buyout of The Medicines Company, many thought cardiovascular therapies were hot again.

Mutations in RIPK1 can cause uncontrolled cell death and inflammation, researchers discovered by studying families with an autoimmune disorder.